Search

Author/Creator Humphries, Pete

2. AAV‐mediated gene therapy improving mitochondrial function provides benefit in age‐related macular degeneration models. Issue 8 (21st August 2022)

Authors:
Millington‐Ward, Sophia; Chadderton, Naomi; Finnegan, Laura K.; Post, Iris J.M.; Carrigan, Matthew; Gardiner, Tom; Peixoto, Elisa; Maloney, Daniel; Humphries, Marian M.; Stitt, Alan; Léveillard, Thierry; Humphries, Pete; Kenna, Paul F.; Palfi, Arpad; Farrar, G. Jane
Journal:
Clinical and translational medicine
Issue:
Volume 12:Issue 8(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

Authors:
Kenna, Paul F; Humphries, Marian M; Kiang, Anna-Sophia; Brabet, Philippe; Guillou, Laurent; Ozaki, Ema; Campbell, Matthew; Farrar, G Jane; Koenekoop, Robert; Humphries, Pete
Journal:
BMJ open ophthalmology
Issue:
Volume 5:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

Authors:
Kenna, Paul F; Humphries, Marian M; Kiang, Anna-Sophia; Brabet, Philippe; Guillou, Laurent; Ozaki, Ema; Campbell, Matthew; Farrar, G Jane; Koenekoop, Robert; Humphries, Pete
Journal:
BMJ open ophthalmology
Issue:
Volume 5:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

Authors:
Kenna, Paul F; Humphries, Marian M; Kiang, Anna-Sophia; Brabet, Philippe; Guillou, Laurent; Ozaki, Ema; Campbell, Matthew; Farrar, G Jane; Koenekoop, Robert; Humphries, Pete
Journal:
BMJ open ophthalmology
Issue:
Volume 5:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

Authors:
Kenna, Paul F; Humphries, Marian M; Kiang, Anna-Sophia; Brabet, Philippe; Guillou, Laurent; Ozaki, Ema; Campbell, Matthew; Farrar, G Jane; Koenekoop, Robert; Humphries, Pete
Journal:
BMJ open ophthalmology
Issue:
Volume 5:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

Authors:
Kenna, Paul F; Humphries, Marian M; Kiang, Anna-Sophia; Brabet, Philippe; Guillou, Laurent; Ozaki, Ema; Campbell, Matthew; Farrar, G Jane; Koenekoop, Robert; Humphries, Pete
Journal:
BMJ open ophthalmology
Issue:
Volume 5:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

Authors:
Kenna, Paul F; Humphries, Marian M; Kiang, Anna-Sophia; Brabet, Philippe; Guillou, Laurent; Ozaki, Ema; Campbell, Matthew; Farrar, G Jane; Koenekoop, Robert; Humphries, Pete
Journal:
BMJ open ophthalmology
Issue:
Volume 5:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

Authors:
Kenna, Paul F; Humphries, Marian M; Kiang, Anna-Sophia; Brabet, Philippe; Guillou, Laurent; Ozaki, Ema; Campbell, Matthew; Farrar, G Jane; Koenekoop, Robert; Humphries, Pete
Journal:
BMJ open ophthalmology
Issue:
Volume 5:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

Authors:
Kenna, Paul F; Humphries, Marian M; Kiang, Anna-Sophia; Brabet, Philippe; Guillou, Laurent; Ozaki, Ema; Campbell, Matthew; Farrar, G Jane; Koenekoop, Robert; Humphries, Pete
Journal:
BMJ open ophthalmology
Issue:
Volume 5:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗